ORTEXORTEX News
Live short interest, options flow, and signals — free on ORTEX.Sign up free →
Market Commentary

Schwab Founder Dumps $35M; BSX CEO Buys Big

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 1 min read

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

Insider activity picked up sharply this week, with executives filing notable trades across finance, energy, and healthcare.

Charles Schwab, founder and Co-Chairman of SCHW, filed sales totaling over $35M in recent days. He sold roughly 332,000 shares across five separate transactions. His daughter, director Carolyn Schwab-Pomerantz, also filed sales worth nearly $5M. The combined family selling at SCHW stands out as one of the week's largest insider exit clusters.

In energy, billionaire Carlos Slim Helu filed the sale of over $36.6M worth of PBF Energy shares. The trades took place on July 30 and were reported this week. A senior vice president at PBF also filed a separate $1.8M sale.

Against the selling wave, Boston Scientific CEO Michael Mahoney filed a $9M purchase of BSX shares on August 3. That trade, reported August 5, signals confidence from the top. Mahoney bought 186,240 shares at around $48 each.

Two PFE directors — Ronald Blaylock and Tim Buckley — both filed purchases worth roughly $1M each on August 5. The coordinated buying at Pfizer is rare and may reflect a view that the stock is undervalued.

LTH Life Time Group CEO Bahram Akradi filed the sale of $19.5M in shares, with three separate insiders at the fitness company filing exits totalling nearly $24.5M in total.

Stocks in this article

How this article was generated

Generated
6 Aug 2026, 20:14
Prompt version
v1.0
Data sources
Institutional positioning

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.